DEFA14A ·Filed Apr 16, 2026

EBS

Emergent BioSolutions Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0001193125-26-158138
Proxy solicitation materials
Actionable Insight • Neutral

No trading catalyst is present in this filing. The proxy statement is a standard disclosure for an upcoming shareholder meeting. Traders should monitor for any subsequent filings related to voting results or changes in corporate strategy, but this document alone does not signal a material event.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
EBS ▼ -7.08% at T+60d
NEUTRAL call ✗ call lost -7.08% · α vs SPY -14.12% · entry $8.62 → $8.01
Entry anchored
Apr 15, 03:59 PM ET
via exchange tick
T+1d
+2.20%
call +2.20% · α +0.99%
$8.81
settled 6mo ago
T+5d
-6.15%
call -6.15% · α -7.13%
$8.09
settled 5mo ago
T+20d
-3.36%
call -3.36% · α -9.18%
$8.33
settled 5mo ago
T+60d
-7.08%
call -7.08% · α -14.12%
$8.01
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Emergent BioSolutions Inc. (EBS) filed its definitive proxy statement (DEFA14A) for its 2026 Annual Meeting of Stockholders, scheduled for April 29, 2026. The filing outlines proposals for shareholder voting, including director elections and executive compensation, as part of routine corporate governance. No material changes or activist challenges are indicated.

Key Facts

  • Filing is a routine proxy statement (DEFA14A) for the 2026 Annual Meeting of Stockholders
  • Meeting date set for April 29, 2026
  • No indication of dissident or activist involvement
  • Proposals include standard items: election of directors, executive compensation, and shareholder proposals

Financial Impact

No immediate financial impact

none

Risk Factors

  • Low risk of unexpected shareholder proposals or voting outcomes given the routine nature of the filing

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-158138
Document: 0001193125-26-158138-index-headers.html0001193125-26-158138
Document: 0001193125-26-158138-index.html0001193125-26-158138
Document: 0001193125-26-158138.txt0001193125-26-158138
16 reports for EBS
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+20▲ +14.89%Apr 29, 2026
Filters
Rows
Reports for EBS — sortable, filterable
TypeNow
Aug 10, 2026
7w ago
Press Release
BEARISH ★ 7/10
$4.45 $5.68▼ −27.64%▼ −28.70%$6.29 (−41.35%)
Jun 29, 2026
13w ago
8-K
BULLISH ★ 5/10
$8.46 $7.26▼ −14.18%▼ −13.90%$6.29 (−25.65%)
Jun 4, 2026
17w ago
Press Release
NEUTRAL ★ 2/10
$8.44 $8.28▼ −1.90%▼ −0.52%$6.29 (−25.47%)
Apr 30, 2026
22w ago
Press Release
MIXED ★ 6/10
$8.47 $8.49▲ +0.24%▼ −5.05%$6.29 (−25.74%)
Apr 30, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.23 $9.18▲ +11.54%▲ +6.58%$6.29 (−23.57%)
Apr 29, 2026
22w ago
Press Release
BULLISH ★ 4/10
$7.99 $9.18▲ +14.89%▲ +8.85%$6.29 (−21.28%)
Apr 29, 2026
22w ago
Press Release
NEUTRAL ★ 1/10
$7.99 $9.18▲ +14.89%▲ +8.85%$6.29 (−21.28%)
Apr 28, 2026
22w ago
DEFA14A
NEUTRAL ★ 2/10
$8.23 $9.13▲ +10.94%▲ +5.47%$6.29 (−23.57%)
Apr 28, 2026
22w ago
Press Release
NEUTRAL ★ 4/10
$8.23 $9.13▲ +10.94%▲ +5.47%$6.29 (−23.57%)
Apr 27, 2026
22w ago
DEFA14A
NEUTRAL ★ 2/10
$8.23 $9.13▲ +10.94%▲ +5.47%$6.29 (−23.57%)
Showing 10 of 16

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access